Volume 9, Issue 3 pp. 340-342

Successful induction of immune tolerance in a patient with haemophilia B with inhibitor

N. Suzuki

N. Suzuki

Department of Pediatrics, Sapporo Medical University School of Medicine, Chuo-Ku, Sapporo, Japan

Search for more papers by this author
J. Watanabe

J. Watanabe

Department of Pediatrics, Sapporo Medical University School of Medicine, Chuo-Ku, Sapporo, Japan

Search for more papers by this author
T. Kudoh

T. Kudoh

Department of Pediatrics, Sapporo Medical University School of Medicine, Chuo-Ku, Sapporo, Japan

Search for more papers by this author
T. Hori

T. Hori

Department of Pediatrics, Sapporo Medical University School of Medicine, Chuo-Ku, Sapporo, Japan

Search for more papers by this author
N. Hatakeyama

N. Hatakeyama

Department of Pediatrics, Sapporo Medical University School of Medicine, Chuo-Ku, Sapporo, Japan

Search for more papers by this author
N. Mizue

N. Mizue

Department of Pediatrics, Sapporo Medical University School of Medicine, Chuo-Ku, Sapporo, Japan

Search for more papers by this author
T. Oda

T. Oda

Department of Pediatrics, Sapporo Medical University School of Medicine, Chuo-Ku, Sapporo, Japan

Search for more papers by this author
H. Tsutsumi

H. Tsutsumi

Department of Pediatrics, Sapporo Medical University School of Medicine, Chuo-Ku, Sapporo, Japan

Search for more papers by this author
First published: 10 April 2003
Citations: 5
Dr N. Suzuki, Department of Pediatrics, Sapporo Medical University School of Medicine, South-1 West-16, Chuo-Ku, Sapporo 060-8543, Japan. Tel.: +81 11 611 2111; fax: +81 11 611 0352; e-mail: [email protected]

Summary.

We describe successful induction of immune tolerance (IT) in a 10-month-old boy with severe haemophilia B. Urticaria developed soon after starting prophylactic treatment and was associated with an inhibitor at 7 Bethesda units mL−1. Initially, we tried low dose factor IX therapy to induce IT with only a transient effect. The patient experienced an intracranial haemorrhage. A simple bolus dose of FIX eradicated the inhibitor. Thereafter he has been free from inhibitor and nephrotic syndrome for more than 5 years, although he receives FIX three times a week.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.